RecruitingPhase 3NCT07064473EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular DiseaseSponsor: Boehringer IngelheimAustin, TX · Brownsville, TX · +205 more sites
RecruitingPhase 2NCT07502508Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based TherapySponsor: Biomea Fusion Inc.Austin, TX · Dallas, TX · Houston, TX · +14 more sites
RecruitingPhase 2NCT07546929HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 DiabetesSponsor: Housey Healthcare ULCDallas, TX · Irving, TX · Lewisville, TX · +22 more sites